Cargando…
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide
BACKGROUND: Targeting influential factors in resistance to chemotherapy is one way to increase the effectiveness of chemotherapeutics. The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway overexpresses in chronic lymphocytic leukemia (CLL) cells and appears to have a significant part in th...
Autores principales: | Khodakarami, Atefeh, Kashani, Mahsa Afsari, Nazer, Atefeh, Kheshti, Armin Mahmoudsalehi, Rashidi, Bentolhoda, Karpisheh, Vahid, Masjedi, Ali, Abolhasani, Shiva, Izadi, Sepideh, Bagherifar, Rafieh, Hejazian, Seyyed Sina, Mohammadi, Hamed, Movassaghpour, AliAkbar, Feizi, Abbas Ali Hosseinpour, Hojjat-Farsangi, Mohammad, Jadidi-Niaragh, Farhad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391779/ https://www.ncbi.nlm.nih.gov/pubmed/37528446 http://dx.doi.org/10.1186/s12964-023-01213-1 |
Ejemplares similares
-
The molecular biology and therapeutic potential of Nrf2 in leukemia
por: Khodakarami, Atefeh, et al.
Publicado: (2022) -
The prognostic and therapeutic potential of HO-1 in leukemia and MDS
por: Sadeghi, Mohammad, et al.
Publicado: (2023) -
Current Advances in Nanotechnology-Mediated Delivery of Herbal and Plant-Derived Medicines
por: Jalili, Amir, et al.
Publicado: (2023) -
The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
por: Kalaei, Zahra, et al.
Publicado: (2023) -
The role of Th17 cells in the pathogenesis and treatment of breast cancer
por: Karpisheh, Vahid, et al.
Publicado: (2022)